Fuji Pharma Co., Ltd. (FRA:FUP)

Fuji Pharma Statistics

Total Valuation

Fuji Pharma has a market cap or net worth of EUR 321.76 million. The enterprise value is 470.12 million.

Market Cap	321.76M
Enterprise Value	470.12M

Important Dates

The last earnings date was Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Current Share Class	24.47M
Shares Outstanding	n/a
Shares Change (YoY)	+0.50%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	41.38%
Owned by Institutions (%)	12.97%
Float	11.68M

Valuation Ratios

The trailing PE ratio is 25.39.

PE Ratio	25.39
Forward PE	n/a
PS Ratio	1.09
PB Ratio	1.24
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	37.10
EV / Sales	1.57
EV / EBITDA	8.12
EV / EBIT	13.15
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.64.

Current Ratio	1.57
Quick Ratio	0.83
Debt / Equity	0.64
Debt / EBITDA	2.88
Debt / FCF	n/a
Interest Coverage	19.31

Financial Efficiency

Return on equity (ROE) is 4.88% and return on invested capital (ROIC) is 7.41%.

Return on Equity (ROE)	4.88%
Return on Assets (ROA)	4.31%
Return on Invested Capital (ROIC)	7.41%
Return on Capital Employed (ROCE)	10.40%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	168,441
Profits Per Employee	7,201
Employee Count	1,760
Asset Turnover	0.58
Inventory Turnover	1.49

Taxes

In the past 12 months, Fuji Pharma has paid 2.67 million in taxes.

Income Tax	2.67M
Effective Tax Rate	17.39%

Stock Price Statistics

The stock price has increased by +51.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+51.45%
50-Day Moving Average	10.61
200-Day Moving Average	8.98
Relative Strength Index (RSI)	77.49
Average Volume (20 Days)	8

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Fuji Pharma had revenue of EUR 296.46 million and earned 12.67 million in profits. Earnings per share was 0.52.

Revenue	296.46M
Gross Profit	121.01M
Operating Income	35.46M
Pretax Income	15.34M
Net Income	12.67M
EBITDA	57.38M
EBIT	35.46M
Earnings Per Share (EPS)	0.52

Balance Sheet

The company has 18.43 million in cash and 165.51 million in debt, with a net cash position of -147.08 million.

Cash & Cash Equivalents	18.43M
Total Debt	165.51M
Net Cash	-147.08M
Net Cash Per Share	n/a
Equity (Book Value)	260.47M
Book Value Per Share	10.64
Working Capital	99.87M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 40.82%, with operating and profit margins of 11.96% and 4.27%.

Gross Margin	40.82%
Operating Margin	11.96%
Pretax Margin	5.17%
Profit Margin	4.27%
EBITDA Margin	19.36%
EBIT Margin	11.96%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.05%.

Dividend Per Share	0.27
Dividend Yield	2.05%
Dividend Growth (YoY)	2.87%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-0.50%
Shareholder Yield	1.55%
Earnings Yield	3.94%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 27, 2018. It was a forward split with a ratio of 2.

Last Split Date	Jun 27, 2018
Split Type	Forward
Split Ratio	2

Scores

Fuji Pharma has an Altman Z-Score of 2.02 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.02
Piotroski F-Score	5